Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|December 24, 2019
Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control studyHanna Kann, Maria Hortlund, Carina Eklund, et al.
The Journal of Infectious Diseases|October 3, 2020
Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity CohortHanna Kann, Matti Lehtinen, Tiina Eriksson, et al.
Frontiers in Immunology|May 30, 2023
A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike proteinSamuel B Lundin, Hanna Kann, Alma Fulurija, et al.
International Journal of Cancer|June 24, 2020
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coveragePenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2Johan Ringlander, Joshua Fingal, Hanna Kann, et al.
Plos Medicine|June 7, 2021
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trialPenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
NPJ Vaccines|August 13, 2024
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort studyPenelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2025
Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three dosesLívia Zignago Moreira Dos Santos, Camila Cristina Martini Rodrigues, Karina Takesaki Miyaji, et al.
The Lancet. Infectious Diseases|June 3, 2021
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trialsFilipe Colaço Mariz, Penelope Gray, Noemi Bender, et al.
Ebiomedicine|December 12, 2025
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settingsJohannes M A Kusters, Nicole Brenner, Johannes A Bogaards, et al.
Pageof 2